Group One Trading
NRXP icon

Group One Trading’s NRX Pharmaceuticals NRXP Stock Holding History

Group One Trading’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$88K Buy
+30,143
New +$107K ﹤0.01% 4812
2026
Q2 		– Sell
-737
Closed -$2.43K – 8198
2026
Q1 		$1.57K Buy
+737
New +$1.49K ﹤0.01% 7116
2025
Q3 		– Sell
-3,108
Closed -$8.9K – 8898
2025
Q2 		$10.1K Buy
+3,108
New +$7.79K ﹤0.01% 6711
2025
Q1 		– Sell
-99
Closed -$279 – 8112
2024
Q4 		$218 Buy
+99
New +$133 ﹤0.01% 7058
2024
Q2 		– Sell
-91
Closed -$428 – 7231
2024
Q1 		$428 Sell
91
-1,825
-95% -$8.41K ﹤0.01% 6756
2023
Q4 		$8.81K Hold
1,916
– – ﹤0.01% 6273
2023
Q3 		$4.98K Sell
1,916
-570
-23% -$1.9K ﹤0.01% 6710
2023
Q2 		$12K Buy
2,486
+353
+17% +$2.12K ﹤0.01% 6293
2023
Q1 		$14.1K Sell
2,133
-2,517
-54% -$25.5K ﹤0.01% 5751
2022
Q4 		$51.6K Sell
4,650
-6,708
-59% -$67.6K ﹤0.01% 4970
2022
Q3 		$84K Sell
11,358
-5,934
-34% -$40K ﹤0.01% 4929
2022
Q2 		$104K Buy
17,292
+13,903
+410% +$183K ﹤0.01% 4955
2022
Q1 		$83K Buy
3,389
+2,763
+441% +$89.9K ﹤0.01% 5675
2021
Q4 		$30K Sell
626
-131
-17% -$9.45K ﹤0.01% 6727
2021
Q3 		$70K Buy
+757
New +$98.5K ﹤0.01% 6260

Other funds holding NRXP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Prime Capital Investment Advisors
Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return

Group One Trading's NRXP Position: Q3 2026 in Review

Group One Trading opened a new position in NRX Pharmaceuticals (NRXP) in Q3 2026: 30,143 shares worth $88K. The stake represents ﹤0.01% of the portfolio and ranks #4812 among its holdings. This is a return to the name: Group One Trading previously reported a position in NRXP as recently as Q1 2026.

Group One Trading first reported a position in NRXP in Q3 2021 and has held it in 15 quarters since. The position peaked at $104K in Q2 2022. 33 funds tracked by Wall St. Rank hold NRXP as of Q3 2026.

  • Group One Trading held 30,143 shares of NRX Pharmaceuticals worth $88K as of Q3 2026.
  • NRX Pharmaceuticals was a new Group One Trading position in Q3 2026.
  • NRX Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #4812 holding.
  • Group One Trading first reported a position in NRX Pharmaceuticals in Q3 2021 and has held it in 15 quarters since.
  • Group One Trading's NRX Pharmaceuticals position peaked at $104K in Q2 2022.
  • 33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.